[
  {
    "ts": "2025-12-04T04:33:52+00:00",
    "headline": "3 Cash-Producing Stocks We Find Risky",
    "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
    "url": "https://finance.yahoo.com/news/3-cash-producing-stocks-risky-043352004.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "e6cebb94-8d13-3b3a-a453-863e60e7eff4",
      "content": {
        "id": "e6cebb94-8d13-3b3a-a453-863e60e7eff4",
        "contentType": "STORY",
        "title": "3 Cash-Producing Stocks We Find Risky",
        "description": "",
        "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
        "pubDate": "2025-12-04T04:33:52Z",
        "displayTime": "2025-12-04T04:33:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/b0711d13dc39117ee969aace421b7405",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "HLMN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mdQQ8JBX9X32zWzK_RhI3A--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/b0711d13dc39117ee969aace421b7405.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.WX576h7miWNfvcu9wKa.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/b0711d13dc39117ee969aace421b7405.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-cash-producing-stocks-risky-043352004.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-cash-producing-stocks-risky-043352004.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OGN"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "HLMN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T16:30:08+00:00",
    "headline": "Why Is Beam Therapeutics (BEAM) Up 15.9% Since Last Earnings Report?",
    "summary": "Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finance.yahoo.com/news/why-beam-therapeutics-beam-15-163008051.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "367917c6-2caf-3f94-a3bf-b3da8d58410f",
      "content": {
        "id": "367917c6-2caf-3f94-a3bf-b3da8d58410f",
        "contentType": "STORY",
        "title": "Why Is Beam Therapeutics (BEAM) Up 15.9% Since Last Earnings Report?",
        "description": "",
        "summary": "Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "pubDate": "2025-12-04T16:30:08Z",
        "displayTime": "2025-12-04T16:30:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85",
          "originalWidth": 900,
          "originalHeight": 636,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eN0EvS2DQjGO_6Aa8hYV4w--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85.cf.webp",
              "width": 900,
              "height": 636,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IXPNK2bXbxtvuH6_.DBDbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-beam-therapeutics-beam-15-163008051.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-beam-therapeutics-beam-15-163008051.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BEAM"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]